Global Biopharmaceuticals Market Study 2016-2026, by Segment (Monoclonal Antibodies , Interferon , … …), by Market (Tumor , Diabetes , … …), by Company (Roche , Amgen , … …)
SKU ID :99ST-14557132 | Published Date: 26-Sep-2019 | No. of pages: 52Description
Summary
The global Biopharmaceuticals market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Monoclonal Antibodies
Interferon
Colony-Stimulating Factor
Erythropoietin
Insulin
Vaccines
Growth Hormones
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Tumor
Diabetes
Cardiovascular
Hemophilia
Others
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
North America
Europe
Asia-Pacific
South America
Middle East & Africa
The global Biopharmaceuticals market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Monoclonal Antibodies
Interferon
Colony-Stimulating Factor
Erythropoietin
Insulin
Vaccines
Growth Hormones
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Tumor
Diabetes
Cardiovascular
Hemophilia
Others
Company Coverage (Sales data, Main Products & Services etc.):
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Major Region
MarketNorth America
Europe
Asia-Pacific
South America
Middle East & Africa
TOC
Tables & Figures
Companies
- PRICE
-
$1800$3600Buy Now